Literature DB >> 32599159

Childhood COVID-19: a multicentre retrospective study.

Z Chen1, L Tong1, Y Zhou1, C Hua1, W Wang1, J Fu2, Q Shu3, L Hong4, H Xu5, Z Xu6, Y Chen1, Y Mao7, S Ye1, X Wu8, L Wang9, Y Luo4, X Zou6, X Tao1, Y Zhang5.   

Abstract

OBJECTIVES: To investigate the clinical and epidemiological characteristics of paediatric patients with coronavirus disease-19 (COVID-19).
METHODS: Paediatric patients diagnosed with COVID-19 between January 15 and March 15, 2020, from seven hospitals in Zhejiang Province, China, were collected retrospectively and analysed.
RESULTS: Thirty-two children with COVID-19, ranging in age from 3 months to 18 years, were enrolled. Family aggregation occurred in 87.5% of infant and preschool-aged children (7/8), and also school-aged children (14/16), but in only 12.5% (1/8) of adolescents (p < 0.05, p < 0.001). Most of these patients had mild symptoms: mainly fever (20/32) followed by cough (10/32) and fatigue (4/32). The average durations of viral RNA in respiratory samples and gastrointestinal samples were 15.8 d and 28.9 d, respectively. Detox duration in faeces decreased with age: 39.8 d, 27.5 d and 20.4 d in infants and preschool children, school children, and adolescents respectively (p0-6, -18 <0.01, p0-6, -14 <0.05). Pneumonia was found in 14 children, but there was no statistical significance in the incidence of pneumonia between different age groups. Thirty patients were treated with antiviral drugs, and all patients were stable and gradually improved after admission.
CONCLUSIONS: Most children with COVID-19 had a mild process and a good prognosis. More attention should be paid to investigation of household contact history in the diagnosis of COVID-19 in young children. Viral RNA lasts longer in the gastrointestinal system than in the respiratory tract, especially in younger children.
Copyright © 2020 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Child; Coronavirus disease-19; Diagnosis; Outcome; Treatment

Year:  2020        PMID: 32599159      PMCID: PMC7319932          DOI: 10.1016/j.cmi.2020.06.015

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


Introduction

The newly emerging infectious disease, coronavirus disease-19 (COVID-19), has now become prevalent all over the world, causing widespread concern. Children are a special group with immature immune systems and respiratory systems which make the disease process and manifestation different from those in adults [1,2]. To summarize the clinical experience in the diagnosis and treatment of paediatric COVID-19, we retrospectively collected and analysed the clinical data of 32 confirmed paediatric patients from seven hospitals in Zhejiang province, eastern China.

Methods

Data collection

We collected 36 children with COVID-19. Of these, four patients were excluded due to incomplete clinical data. Clinical characteristics and laboratory examinations as well as radiological and microbiological findings were recorded and analysed. This study was approved by the ethics committee of the Children's Hospital, Zhejiang University School of Medicine (EC approval number: 2020-IRB-032).

Real-time reverse-transcriptase polymerase chain reaction (RT-PCR)

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) was detected with primers and probes targeting the ORF1ab and N genes by RT-PCR assay according to the manufacturer's instructions (Shanghai Huirui Biotechnology Co. Ltd, China). A cycle threshold value (Ct value) of ≥40 was defined as a negative test. A Ct value < 37 of both target genes was defined as a positive case; a medium load or only one target gene with a Ct value ≤ 37 was considered to be a suspected case and required confirmation by retesting.

Data analysis

A one-way non-parametric analysis of variance (ANOVA) followed by an unpaired Student's t-test were conducted for comparisons of the parameters between groups. LSD test was used for pairwise comparison between multiple data. Enumeration data were subjected to the χ2 test or Fisher's exact test. All analyses were performed using IBM SPSS Statistics 20 software. Statistical significance was accepted at p < 0.05.

Results

Demographic data

Thirty-two children with an average age of 9.5 years (range 3 months to 18 years) were enrolled (see Table 1 ). All the children were previously healthy.
Table 1

Clinical features of 32 children with confirmed coronavirus disease-19 (COVID-19)

All patients0–6–14–18
Number (male/female) (n)32 (21/11)8 (3/5)16 (13/3)8 (5/3)
Family aggregation n (%)22 (68.75%)7 (87.5%)14 (87.5%)1 (12.5%)
ClassificationMild (n)18576
Common (n)14392
Severe (n)0000
Critical (n)0000
FeverNumber (n)20596
~38°C (n)11254
~39°C (n)9342
>39°C (n)0000
Cough (n)10334
Fatigue (n)4121
Diarrhoea (n)3120
WBC (mean ± SE) (/L)6.69 ± 3.078.83 ± 3.716.02 ± 2.736.19 ± 2.23
Proportion of pneumonia in imaging n (%)14 (43.75%)3/8 (37.5%)9/16 (56.25%)2/8 (25.0%)

WBC, white blood cell count.

Clinical features of 32 children with confirmed coronavirus disease-19 (COVID-19) WBC, white blood cell count.

Epidemiological and clinical data

COVID-19 tended to be clustered in families; 22 of the 32 children had at least one family member a confirmed COVID-19 patient. This phenomenon of family aggregation occurred in 87.5% of infant and preschool-aged children (7/8), 87.5% of school-aged children (14/16), and only 12.5% of adolescents (1/8) (Fisher's exact test, p0–6, –18 <0.05, p–14, –18 <0.001). The clinical manifestations of these patients were generally mild (see Table 1).

Viral RNA detection

We collected sequential viral RNA information from 25 patients. Detailed information is presented in Fig. 1 . The average duration of viral RNA in respiratory samples (nasopharyngeal swab or sputum) was 15.8 d (range 1–29 d). The average durations in infants and preschool children, school children and adolescents were 12.67 ± 8.26 d, 16 ± 7.93 d and 18 ± 8.49 d, respectively, without statistical difference.
Fig. 1

Comparison of respiratory (RT) and gastrointestinal (GI) samples for the detection of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) RNA. (A) RNA duration in respiratory and digestive tracts between different age groups. (B) The dynamic change of SARS-CoV-2 RNA in the respiratory tracts of six typical patients (different colour for each patient). (C) The dynamic change in SARS-CoV-2 RNA in the digestive tracts of five typical patients (different colour for each patient).

Comparison of respiratory (RT) and gastrointestinal (GI) samples for the detection of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) RNA. (A) RNA duration in respiratory and digestive tracts between different age groups. (B) The dynamic change of SARS-CoV-2 RNA in the respiratory tracts of six typical patients (different colour for each patient). (C) The dynamic change in SARS-CoV-2 RNA in the digestive tracts of five typical patients (different colour for each patient). Seventeen children were tested for viral RNA in faeces or anal swabs; viral RNA was present with an average duration of 28.9 ± 11.81 d, with the longest time of 65 d in the youngest case, a 3-month-old girl. Interestingly, the duration of viral RNA in faeces decreased with age, being 39.8 d in infants and preschool children, 27.5 d in school-age children, and 20.4 d in adolescents (LSD test, p0–6, –18 <0.01, p0–6, –14 <0.05) (Fig. 1A). Nine urine tests in two children and five serum tests in one case were all negative. When looking more deeply into the Ct value of virus RNA, as is shown in Fig. 1 (B and C) the viral RNA load in respiratory samples gradually decreased until it became negative, while the viral RNA in faeces tended to fluctuate around a certain value before being cleared.

Chest imaging findings

All patients underwent imaging examinations, including seven chest film and 25 computed tomography scans (CTs). Pneumonia was found in 14 children (Table 1). No statistical significance in the percentage of pneumonia was found among different age groups (p > 0.05). When grouped by gender, a slightly higher proportion of boys had pneumonia, but this did not reach statistical difference (10/21 versus 4/11).

Treatment and outcome

Thirty patients were treated with antiviral drugs, including recombinant interferon (24/30, 80%), lopinavir/ritonavir (15/30, 50%), arbidol (10/30, 33.33%), oseltamivir phosphate (4/30, 13.33%) and ribavirin (3/30,10%). Oseltamivir phosphate was used only in the early course and for a short period. Additionally, traditional Chinese medicine was used in seven children and probiotics were used in five children. Four patients received antibiotics because of suspected bacterial infection. No glucocorticoids or intravenous immunoglobulin (IVIG) were used. All patients were stable and gradually improved after admission. No severe or critical case occurred. The average length of hospital stay was 21.29 d (range 5–32 d).

Discussion

Early clinical investigations suggested that COVID-19 is prevalent predominantly in adults [3,4], with only a small percentage of paediatric patients. According to the latest analysis, the proportion of children under 20 years of age with COVID-19 was only 2.1%, including 0.9% in the 0–10-year age group and 1.2% in the 10–20-year age group [5]. The first confirmed paediatric case of COVID-19 was a 10-year-old boy from a case-gathering family in Shenzhen, Guangdong Province, on January 15, 2020 [1]. Since then, more and more paediatric patients have been reported. The youngest infected case reported so far was 36 h after birth [6]. Here, we collected and analysed data on 32 COVID-19 children from seven hospitals in Zhejiang province. In our study, 22 of these patients (68.75%) had at least one family member a confirmed COVID-19 patient. This phenomenon of family aggregation occurred in 87.5% of infant, preschool-aged children and school-aged children, and in only 12.5% of adolescents. This result can be explained by the limited range of activities of young children. It also highlights the importance of family aggregation history in the clinical diagnosis of paediatric COVID-19, especially for younger children [7]. As in the severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS) and avian influenza A H7N9 outbreaks [8,9], symptoms of paediatric COVID-19 were generally mild [3,10]. Only one fatal paediatric case has been reported so far in China, and the overall severe and critical rate was around 5.8% [11], much lower than that in adults (18.5%) [12]. The dynamics of SARS-CoV-2 in vivo is a focus of research at present. In our study, it was found that the average viral RNA duration in respiratory samples (pharyngeal swab or sputum) was 15.8 d, much longer than the clinical symptoms. Further analysis revealed that gastrointestinal samples (faeces or anal swabs) had a much longer virus duration (28.9 d) than respiratory samples. Interestingly, the duration of virus in the digestive tract decreased with age: 39.8 d in infants and preschool children, 27.5 d in school-age children, and 20.4 d in adolescents. The youngest patient (3 months) showed the longest duration of faecal viral RNA (65 d). This happens to coincide with the fact that the viral RNA shedding in children is much longer than that in adults [13,14]. It is necessary to determine whether there are active virus particles in the faeces. As in other studies [13,15], no positive result for viral RNA was found either in serum or in urine. In summary, COVID-19 in most paediatric cases was characterized by mild symptoms and transient fever with good prognosis. More attention should be paid to investigation of household contact history in the diagnosis of COVID-19 in young children. Viral RNA lasts longer in the gastrointestinal system than in the respiratory tract, especially in younger infants. A limitation of this study is that only 32 patients were involved. Even though we found some interesting phenomena, the limitations of the data prevent us from drawing firm conclusions.

Author contributions

ZC, LT and YZ contributed equally to this work. The study was conceived by QS, JF and ZC. Data collection was performed by CH, WW, LH, HX, ZX, YC, SY, XW, LW, YL, XZ, XT and YZ. Statistical analysis and draft writing were performed by LT and YZ under the leadership of ZC. All authors have read and approved the manuscript.

Transparency declaration

The authors declare that they have no conflict of interests. This programme was supported by fund for COVID-19 prevention and control (2020XGZX0081).
  13 in total

1.  Middle East respiratory syndrome coronavirus disease in children.

Authors:  Ziad A Memish; Jaffar A Al-Tawfiq; Abdullah Assiri; Fahad A AlRabiah; Sami Al Hajjar; Ali Albarrak; Hesham Flemban; Rafat F Alhakeem; Hatem Q Makhdoom; Sarah Alsubaie; Abdullah A Al-Rabeeah
Journal:  Pediatr Infect Dis J       Date:  2014-09       Impact factor: 2.129

2.  Epidemiology of avian influenza A H7N9 virus in human beings across five epidemics in mainland China, 2013-17: an epidemiological study of laboratory-confirmed case series.

Authors:  Xiling Wang; Hui Jiang; Peng Wu; Timothy M Uyeki; Luzhao Feng; Shengjie Lai; Lili Wang; Xiang Huo; Ke Xu; Enfu Chen; Xiaoxiao Wang; Jianfeng He; Min Kang; Renli Zhang; Jin Zhang; Jiabing Wu; Shixiong Hu; Hengjiao Zhang; Xiaoqing Liu; Weijie Fu; Jianming Ou; Shenggen Wu; Ying Qin; Zhijie Zhang; Yujing Shi; Juanjuan Zhang; Jean Artois; Vicky J Fang; Huachen Zhu; Yi Guan; Marius Gilbert; Peter W Horby; Gabriel M Leung; George F Gao; Benjamin J Cowling; Hongjie Yu
Journal:  Lancet Infect Dis       Date:  2017-06-02       Impact factor: 25.071

3.  [The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China].

Authors: 
Journal:  Zhonghua Liu Xing Bing Xue Za Zhi       Date:  2020-02-10

4.  Epidemiology of COVID-19 Among Children in China.

Authors:  Yuanyuan Dong; Xi Mo; Yabin Hu; Xin Qi; Fan Jiang; Zhongyi Jiang; Shilu Tong
Journal:  Pediatrics       Date:  2020-03-16       Impact factor: 7.124

5.  Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.

Authors:  Chaolin Huang; Yeming Wang; Xingwang Li; Lili Ren; Jianping Zhao; Yi Hu; Li Zhang; Guohui Fan; Jiuyang Xu; Xiaoying Gu; Zhenshun Cheng; Ting Yu; Jiaan Xia; Yuan Wei; Wenjuan Wu; Xuelei Xie; Wen Yin; Hui Li; Min Liu; Yan Xiao; Hong Gao; Li Guo; Jungang Xie; Guangfa Wang; Rongmeng Jiang; Zhancheng Gao; Qi Jin; Jianwei Wang; Bin Cao
Journal:  Lancet       Date:  2020-01-24       Impact factor: 79.321

6.  A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster.

Authors:  Jasper Fuk-Woo Chan; Shuofeng Yuan; Kin-Hang Kok; Kelvin Kai-Wang To; Hin Chu; Jin Yang; Fanfan Xing; Jieling Liu; Cyril Chik-Yan Yip; Rosana Wing-Shan Poon; Hoi-Wah Tsoi; Simon Kam-Fai Lo; Kwok-Hung Chan; Vincent Kwok-Man Poon; Wan-Mui Chan; Jonathan Daniel Ip; Jian-Piao Cai; Vincent Chi-Chung Cheng; Honglin Chen; Christopher Kim-Ming Hui; Kwok-Yung Yuen
Journal:  Lancet       Date:  2020-01-24       Impact factor: 79.321

7.  Detection and analysis of nucleic acid in various biological samples of COVID-19 patients.

Authors:  Jianguo Wu; Jiasheng Liu; Shijun Li; Zhiyang Peng; Zhe Xiao; Xufeng Wang; Ruicheng Yan; Jianfei Luo
Journal:  Travel Med Infect Dis       Date:  2020-04-18       Impact factor: 6.211

Review 8.  Review article: gastrointestinal features in COVID-19 and the possibility of faecal transmission.

Authors:  Yuan Tian; Long Rong; Weidong Nian; Yan He
Journal:  Aliment Pharmacol Ther       Date:  2020-03-31       Impact factor: 8.171

9.  Persistence and clearance of viral RNA in 2019 novel coronavirus disease rehabilitation patients.

Authors:  Yun Ling; Shui-Bao Xu; Yi-Xiao Lin; Di Tian; Zhao-Qin Zhu; Fa-Hui Dai; Fan Wu; Zhi-Gang Song; Wei Huang; Jun Chen; Bi-Jie Hu; Sheng Wang; En-Qiang Mao; Lei Zhu; Wen-Hong Zhang; Hong-Zhou Lu
Journal:  Chin Med J (Engl)       Date:  2020-05-05       Impact factor: 2.628

Review 10.  COVID-19 epidemic: Disease characteristics in children.

Authors:  Jiatong She; Lanqin Liu; Wenjun Liu
Journal:  J Med Virol       Date:  2020-04-15       Impact factor: 20.693

View more
  9 in total

1.  [Fatigue Doesn't Always have to be caused by SARS-CoV-2: Case Report].

Authors:  Helmuth Howanietz; Ulrike Graf; Theresa Kainz
Journal:  Padiatr Padol       Date:  2022-05-19

Review 2.  Epidemiology and pathobiology of SARS-CoV-2 (COVID-19) in comparison with SARS, MERS: An updated overview of current knowledge and future perspectives.

Authors:  Balasubramanian Ganesh; Thangarasu Rajakumar; Mathiyazhakan Malathi; Natesan Manikandan; Jaganathasamy Nagaraj; Aridoss Santhakumar; Arumugam Elangovan; Yashpal Singh Malik
Journal:  Clin Epidemiol Glob Health       Date:  2021-01-14

3.  Epidemiological Study on Mycoplasma pneumoniae and Chlamydia pneumoniae Infection of Hospitalized Children in a Single Center During the COVID-19 Pandemic.

Authors:  Fengqing Cai; Xinyi Shou; Qing Ye
Journal:  Front Cell Infect Microbiol       Date:  2022-03-21       Impact factor: 5.293

4.  Children's role in the COVID-19 pandemic: a systematic review of early surveillance data on susceptibility, severity, and transmissibility.

Authors:  Katy A M Gaythorpe; Sangeeta Bhatia; Tara Mangal; H Juliette T Unwin; Natsuko Imai; Gina Cuomo-Dannenburg; Caroline E Walters; Elita Jauneikaite; Helena Bayley; Mara D Kont; Andria Mousa; Lilith K Whittles; Steven Riley; Neil M Ferguson
Journal:  Sci Rep       Date:  2021-07-06       Impact factor: 4.379

5.  Low impact of SARS-CoV-2 infection among paediatric acute respiratory disease hospitalizations.

Authors:  Maria Melé; Desiree Henares; Rosa Pino; Silvia Asenjo; Rocío Matamoros; Victoria Fumadó; Claudia Fortuny; Juan-José García-García; Iolanda Jordan; Pedro Brotons; Carmen Muñoz-Almagro; Mariona-Fernández de-Sevilla; Cristian Launes
Journal:  J Infect       Date:  2020-10-21       Impact factor: 6.072

Review 6.  COVID-19 in clinical practice: A narrative synthesis.

Authors:  M Le Maréchal; P Morand; O Epaulard; B Némoz
Journal:  Med Mal Infect       Date:  2020-09-29       Impact factor: 2.152

7.  Transmission of SARS-CoV-2 through breast milk and breastfeeding: a living systematic review.

Authors:  Elizabeth Centeno-Tablante; Melisa Medina-Rivera; Julia L Finkelstein; Pura Rayco-Solon; Maria Nieves Garcia-Casal; Lisa Rogers; Kate Ghezzi-Kopel; Pratiwi Ridwan; Juan Pablo Peña-Rosas; Saurabh Mehta
Journal:  Ann N Y Acad Sci       Date:  2020-08-28       Impact factor: 5.691

Review 8.  Twelve Months with COVID-19: What Gastroenterologists Need to Know.

Authors:  Giulia Concas; Michele Barone; Ruggiero Francavilla; Fernanda Cristofori; Vanessa Nadia Dargenio; Rossella Giorgio; Costantino Dargenio; Vassilios Fanos; Maria Antonietta Marcialis
Journal:  Dig Dis Sci       Date:  2021-07-31       Impact factor: 3.487

9.  Systematic review with meta-analysis: SARS-CoV-2 stool testing and the potential for faecal-oral transmission.

Authors:  Amarylle S van Doorn; Berrie Meijer; Chris M A Frampton; Murray L Barclay; Nanne K H de Boer
Journal:  Aliment Pharmacol Ther       Date:  2020-08-27       Impact factor: 9.524

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.